125 related articles for article (PubMed ID: 2124435)
1. [UFT-MT therapy in advanced or recurrent breast cancer].
Yamaguchi S; Komoriyama H; Tsukikawa S; Imaki S; Morikubo M; Asakura T; Okamura R; Fukuda M; Kanasugi K; Watanabe H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2437-41. PubMed ID: 2124435
[No Abstract] [Full Text] [Related]
2. [Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Hozumi T; Katou J; Okutani T; Irie K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2373-9. PubMed ID: 2502072
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
Aoki Y; Tabuse Y; Tanimura H; Katsumi M; Asae M; Ichimiya G; Imai T; Ooshima K; Kakihara M; Kashitani M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):225-34. PubMed ID: 2493222
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of combination therapy consisting of cyclophosphamide, adriamycin, UFT and oophorectomy/tamoxifen for advanced or recurrent breast cancer].
Kiman K; Suzuki S; Satomi T; Sakonji M; Nihei M; Tanaka T; Kimijima I; Abe R
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2445-52. PubMed ID: 7944490
[TBL] [Abstract][Full Text] [Related]
5. [PMU therapy of recurrent gastric cancer. A case report].
Ohyama S; Yonemura Y; Matsuki N; Miyata R; Noto H; Sakuma H; Yagi M; Sawa T; Ogino S; Miyazaka I
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):612-5. PubMed ID: 3006596
[TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
Noguchi S; Koyama H; Uchino J; Abe R; Miura S; Sugimachi K; Akazawa K; Abe O
J Clin Oncol; 2005 Apr; 23(10):2172-84. PubMed ID: 15800310
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of prognostic factors in patients with locally advanced breast cancer treated with intra-arterial infusion chemotherapy as an induction therapy].
Inaji H; Noguchi S; Yamamoto H; Koyama H; Iwanaga T; Wada A
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2910-2. PubMed ID: 2506829
[TBL] [Abstract][Full Text] [Related]
8. [Tamoxifen plus tegafur plus low-dose adriamycin in the treatment of advanced breast cancer in an outpatient basis].
Shiba E; Koyama H; Noguchi S; Nishizawa Y; Iwanaga T; Terasawa T
Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2196-201. PubMed ID: 3128615
[No Abstract] [Full Text] [Related]
9. [Neoadjuvant therapy followed by administration of UFT for breast cancer patients].
Kataoka T; Goto T; Haruta R; Dohi K
Gan To Kagaku Ryoho; 1996 Feb; 23(3):369-72. PubMed ID: 8712833
[No Abstract] [Full Text] [Related]
10. [Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Watanabe O; Shimizu T; Imamura H; Kinoshita J; Okabe T; Ogawa K; Haga S
Gan To Kagaku Ryoho; 2004 May; 31(5):717-21. PubMed ID: 15170979
[TBL] [Abstract][Full Text] [Related]
11. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
Toi M; Ikeda T; Akiyama F; Kurosumi M; Tsuda H; Sakamoto G; Abe O
Int J Oncol; 2007 Oct; 31(4):899-906. PubMed ID: 17786323
[TBL] [Abstract][Full Text] [Related]
12. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
13. [A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
Adachi M; Sasaki M
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2856-7. PubMed ID: 3092746
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer].
Kabashima A; Sakaguchi Y; Okita K; Yamamura S; Ojima Y; Nishizaki T; Tashiro H; Matsuzaka T
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1935-8. PubMed ID: 16282730
[TBL] [Abstract][Full Text] [Related]
15. [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Nakata K; Shigemitsu M; Joya K; Sato K; Hara S; Hanawa S
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1694-6. PubMed ID: 3927850
[TBL] [Abstract][Full Text] [Related]
16. [Combined UFTM for 140 patients with advanced gastric cancer].
Jin ML
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):130-2. PubMed ID: 2553364
[TBL] [Abstract][Full Text] [Related]
17. [Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
Sakata Y; Munakata A; Baba T; Saitoh S; Itoh T; Tamura Y; Furukohori N; Suzuki H; Kimura T; Kawata K
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2065-71. PubMed ID: 3134859
[TBL] [Abstract][Full Text] [Related]
18. [A case of local recurrent breast cancer with complete response to combination of systemic chemotherapy and topical use of adriamycin ointment].
Deguchi S; Kurihara K; Nomura K; Hokama A; Muto Y; Toda T
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2253-6. PubMed ID: 2241190
[TBL] [Abstract][Full Text] [Related]
19. [UFT-therapy and UFTM therapy--comparison of survivals in the patients with Borrmann type 4 gastric cancer treated either with UFTM-chemotherapy or operation].
Suga S; Kimura K; Yokoyama Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):769-74. PubMed ID: 6424582
[TBL] [Abstract][Full Text] [Related]
20. UFT and mitomycin plus tamoxifen for stage II, ER-positive breast cancer. Hokkaido ACETBC Study Group.
Hata Y; Uchino J; Asaishi K; Kubo Y; Mito M; Tanabe T; Ogita M; Hirata K
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):91-5. PubMed ID: 10442372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
